3,400+
Viewed by
4.8
Ratings
8
Countries Tracked
5
Suppliers Covered
2
Clients Served
4%
Savings Generated
Category Intelligence on Pharmaceutical Distribution APAC covers the following
The industry is expected to have higher bargain and negotiation power as the market is highly fragmented. Also, implementation of two-invoice system in 2018 is expected to bring down the distributor margins
Manufacturers adopt percentage of sales as a prevalent pricing model by engaging with full-line wholesalers for the distribution of pharmaceutical product.
Engagement Model
Distribution Services
Wholesaler/Distribution Margin
Licensing Authority
Shelf Life
Industry is expected to have higher bargaining power as the market is fragmented and also most of the companies prefer to engage with regional distributors such as Zuellig Pharma and DKSH
General practice is to engage with a single national distributor; however, international manufacturers deal with more than one distributors, based on the product portfolio.
Engagement Model
Distribution Services
Wholesaler/Distribution Margin
Sales Incentives
Licensing Authority
Shelf Life
Pharmaceutical Distribution APAC
Complimentary 12-month access to Beroe LiVE
COVID-19: Assess impact on your suppliers and ensure business continuity with Beroe’s WIRE
(World Instant Risk Exposure)
Beroe is the World's leading provider of Procurement Intelligence and Supplier compliance solutions. We work with over 10,000 companies worldwide, including 400 of the Fortune 500.
© Copyright © 2021 Beroe. All rights reserved.
